Company Filing History:
Years Active: 2000-2001
Title: Innovations by Drew Holmes in Injectable Compositions
Introduction
Drew Holmes is an accomplished inventor based in Bryansford, GB. He has made significant contributions to the field of injectable compositions, particularly focusing on formulations that enhance the efficacy and reduce the side effects of treatments.
Latest Patents
Holmes holds two patents, with his latest innovations centered around long-acting oxytetracycline compositions. These injectable formulations are designed to provide a higher residual effect while minimizing adverse effects such as pain at the injection site, swelling, tissue irritancy, or necrosis. The compositions utilize a tetracycline compound, either in its free base form or as a salt with a physiologically acceptable acid, complexed with a magnesium compound. The formulations are solubilized in a water-miscible solvent system, which includes glycerol formal and polyethylene glycol, and may also contain a pH modifier to maintain a physiologically acceptable pH.
Career Highlights
Drew Holmes is currently associated with Norbrook Laboratories Limited, where he continues to innovate in the field of pharmaceutical compositions. His work has been instrumental in developing formulations that improve patient outcomes and enhance the therapeutic effects of medications.
Collaborations
Holmes collaborates with fellow inventor Alan Patterson, contributing to the advancement of their shared goals in pharmaceutical innovation.
Conclusion
Drew Holmes is a notable inventor whose work in injectable compositions has the potential to significantly impact medical treatments. His innovative approaches to reducing side effects while enhancing efficacy demonstrate his commitment to improving healthcare solutions.